دورية أكاديمية
أعرض في EDS

Online follow-up of individuals with gastroesophageal reflux disease using a patient-reported outcomes instrument: results of an observational study.

التفاصيل البيبلوغرافية
العنوان: Online follow-up of individuals with gastroesophageal reflux disease using a patient-reported outcomes instrument: results of an observational study.
المؤلفون: Tielemans MM; Department of Gastroenterology and Hepatology, Radboud University Medical Center, PO Box 9101, Internal code 455, Nijmegen 6500 HB, The Netherlands. Merel.Tielemans@radboudumc.nl., van Oijen MG
المصدر: BMC gastroenterology [BMC Gastroenterol] 2013 Oct 01; Vol. 13, pp. 144. Date of Electronic Publication: 2013 Oct 01.
نوع المنشور: Journal Article; Observational Study
اللغة: English
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X (Electronic) Linking ISSN: 1471230X NLM ISO Abbreviation: BMC Gastroenterol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : BioMed Central, [2001-
مواضيع طبية MeSH: Information Seeking Behavior* , Internet* , Patient Acceptance of Health Care*, Gastroesophageal Reflux/*physiopathology, Adult ; Disease Progression ; Female ; Gastroesophageal Reflux/drug therapy ; Humans ; Male ; Middle Aged ; Proton Pump Inhibitors/therapeutic use ; Surveys and Questionnaires
مستخلص: Background: Many individuals with gastroesophageal reflux disease (GERD) never visit their general practitioner. Therefore, prospective data about GERD and its natural history in the general population are scarce. The aims of this study were to assess symptoms over time and consultation reasons in an Internet population with GERD.
Methods: Visitors (18-79 years) to a GERD information website who completed the GerdQ self-assessment questionnaire were invited to participate. Follow-up GerdQ questionnaires were sent after 4, 12 and 24 weeks, and those who had a total GerdQ score ≥ 8 and responded to at least the baseline and 4-week questionnaires (within 2-7 weeks) were included in the analyses. Outcome in proton pump inhibitor (PPI) and non-PPI users was classified as symptom improvement, symptom persistence/stable symptoms, or symptom relapse according to GerdQ scores.
Results: A total of 403 non-PPI users (mean age 48 years, 40% male) and 304 PPI users (mean age 51 years, 41% male) were included. After 24 weeks, symptom improvement was present in 66% of non-PPI users (45/68) and 8% of PPI users (6/73), while persisting symptoms were reported by 24% (16/68) and 89% (65/73) respectively (baseline symptoms did not influence outcome at 24 weeks). Fifty-five percent of PPI users (116/210) and 37% of non-PPI users (76/207) who intended to visit a healthcare practitioner, performed one or more healthcare visits in the interim. Most frequently reported reason for consultation was persistence of symptoms.
Conclusions: GERD symptoms were persistent in the majority of PPI users during our 24-week follow-up, while almost two thirds of non-PPI users reported symptom improvement. Online follow-up of an Internet population with GERD is feasible.
References: Health Qual Life Outcomes. 2009 Oct 16;7:90. (PMID: 19835583)
N Engl J Med. 2006 Jan 5;354(1):4-7. (PMID: 16394296)
Aliment Pharmacol Ther. 2012 Jan;35(1):154-64. (PMID: 22070159)
Gastroenterology. 2008 Oct;135(4):1383-1391, 1391.e1-5. (PMID: 18789939)
J Med Internet Res. 2011 Feb 23;13(1):e20. (PMID: 21345783)
Gut. 1992 Aug;33(8):1016-9. (PMID: 1356887)
Aliment Pharmacol Ther. 2013 Mar;37(5):564-72. (PMID: 23289763)
Aliment Pharmacol Ther. 2010 Jul;32(1):29-42. (PMID: 20353496)
Interact J Med Res. 2012 Sep 26;1(2):e7. (PMID: 23611985)
Aliment Pharmacol Ther. 2007 Jun 15;25(12):1451-9. (PMID: 17539985)
Health Qual Life Outcomes. 2008 Apr 30;6:31. (PMID: 18447946)
Qual Life Res. 1998 Jan;7(1):75-83. (PMID: 9481153)
Aliment Pharmacol Ther. 2012 Jun;35(11):1290-300. (PMID: 22510027)
Aliment Pharmacol Ther. 2009 Nov 15;30(10):1030-8. (PMID: 19737151)
Gastroenterology. 1997 May;112(5):1448-56. (PMID: 9136821)
Curr Med Res Opin. 2006 Apr;22(4):657-62. (PMID: 16684426)
Aliment Pharmacol Ther. 2010 Sep;32(6):720-37. (PMID: 20662774)
Aliment Pharmacol Ther. 2009 Aug 15;30(4):331-42. (PMID: 19660016)
BMJ. 2006 Dec 2;333(7579):1143-5. (PMID: 17098763)
BMC Gastroenterol. 2013 Feb 28;13:39. (PMID: 23448382)
Best Pract Res Clin Gastroenterol. 2010 Dec;24(6):759-64. (PMID: 21126691)
Can J Gastroenterol. 2010 Jul;24(7):431-4. (PMID: 20652158)
Gut. 2005 May;54(5):710-7. (PMID: 15831922)
N Engl J Med. 2008 Oct 16;359(16):1700-7. (PMID: 18923172)
Aliment Pharmacol Ther. 2008 May;27(10):960-70. (PMID: 18315585)
المشرفين على المادة: 0 (Proton Pump Inhibitors)
تواريخ الأحداث: Date Created: 20131003 Date Completed: 20140401 Latest Revision: 20211021
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC3851875
DOI: 10.1186/1471-230X-13-144
PMID: 24083342
قاعدة البيانات: MEDLINE
الوصف
تدمد:1471-230X
DOI:10.1186/1471-230X-13-144